Retired, formerly Senior Research Fellow @ Eli Lilly and Company (January 1985 - August 2017)
President @ Inflammation Research Association (September 2010 - September 2012)
Assistant Professor, Cancer Biology @ The Salk Institute (September 1982 - December 1984)
Postdoctoral Fellow @ Swiss Institute for Experimental Cancer Research (June 1980 - September 1982)
Andy Glasebrook Education
The University of Chicago Pritzker School of Medicine
PhD (Immunology)
1976-1980
Carleton College
BA (Biology)
1970-1974
Andy Glasebrook Skills
Drug Discovery
In Vivo
Pharmacology
Lifesciences
Pharmaceutical Industry
Biomarkers
Cell Culture
Oncology
Biochemistry
Inflammation
Immunology
Clinical Development
Molecular Biology
Cancer
Drug Development
Biotechnology
Clinical Trials
Monoclonal Antibodies
Assay Development
Biopharmaceuticals
Antibodies
Clinical Research
Technology Transfer
Cell
In Vitro
Infectious Diseases
High Throughput Screening
ELISA
Translational Medicine
Cell Biology
Translational Research
Protein Chemistry
Vaccines
Life Sciences
Microsoft Office
Teaching
Science
Scientists
Cancer Research
Public Speaking
SAN
Customer Service
Management
Networking
Andy Glasebrook Summary
Andy Glasebrook, based in San Diego, CA, US, is currently a Vice President, Autoimmune Drug Development at Toralgen. Andy Glasebrook brings experience from previous roles at Toralgen, AGbio Consulting, LLC, Eli Lilly and Company and Inflammation Research Association. Andy Glasebrook holds a 1976 - 1980 PhD in Immunology @ The University of Chicago Pritzker School of Medicine. With a robust skill set that includes Drug Discovery, In Vivo, Pharmacology, Lifesciences, Pharmaceutical Industry and more. Andy Glasebrook has 1 mobile phone numbers on RocketReach.
Looking for a different Andy Glasebrook?
Find contact details for 700 million professionals.